# Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/homologous-recombination-deficiency-hrd-can-predict-the-therapeutic-outcomes-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhen Zhou,Zhengping Ding,Jie Yuan,Shengping Shen,Hong Jian,Qiang Tan,Yunhai Yang,Zhiwei Chen,Qingquan Luo,Xinghua Cheng,Yongfeng Yu,Xiaomin Niu,Liqiang Qian,Xiaoke Chen,Linping Gu,Ruijun Liu,Shenglin Ma,Jia Huang,Tianxiang Chen,Ziming Li,Wenxiang Ji,Liwei Song,Lan Shen,Long Jiang,Zicheng Yu,Chao Zhang,Zaixian Tai,Changxi Wang,Rongrong Chen,David P. Carbone,Xuefeng Xia,Shun Lu |
| Citations | 75 |
| DOI | 10.1186/s13045-022-01283-7 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-022-01283-7 |
| OpenAlex ID | https://openalex.org/W4280495239 |
| PMID | 35585646 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Linping Gu](https://scholariq.org/researchers/linping-gu/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.